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.2013.03.0Abstract The present experiments were designed to determine the effect of the exogenous treatment
of Oreochromis niloticus females with L-thyroxin (T4) on the activation of growth hormone (GH)-
secreting cells during larval rearing, and its subsequent effect on larval growth and survival. The
ontogeny ofGH-secreting cells was investigated immunocytochemically in the developingO. niloticus
larvae, from control and T4-treated spawners. A few numbers of GH-immunoreactive cells were
observed early one day after hatching. The number and immunoreactivity of GH-secreting cells
increased with larval development. The injection of females O. niloticus with thyroxin (1 or 10 lg
T4/g BW) greatly enhanced the immunoreactivity ofGH-secreting cells in the pituitary gland of larvae
as indicated by the quantitative and qualitative changes; the increase of both number and size, and
strong immunoreactivities of GH-secreting cells, during the rearing period for the larvae produced
from T4-treated females. Thus, thyroxin directly improved O. niloticus larval growth, since a marked
increase in both, the length andweight of larvae occurred during the experimental period. In addition,
larvae from treated females also gave a signiﬁcantly higher survival rate than that of the control.
It could be concluded that exogenous T4 in maternal circulation was transferred into oocytes and
larvae. The transferred thyroid hormone appears to play a main role in the synthesis and secretion
of GH during the early development of larvae and may confer a distinct advantage for the growth
of the offspring of Nile tilapia, O. niloticus.
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02Introduction
Growth hormone (GH) is a pluripotent hormone produced by
the pituitary gland in teleosts as in other vertebrates. GH may
play important physiological functions in the embryonic and
larval development of ﬁsh (Yang et al., 1999; Einarsdo´ttir
et al., 2007; Cao et al., 2011). In ﬁsh, GH participates in almost
all major physiological processes in the body including theational Institute of Oceanography and Fisheries.
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carbohydrate metabolism, skeletal and soft tissue growth,
reproduction and immune function. Recent studies have indi-
cated that GH affects several aspects of behaviour, including
appetite, foraging behaviour, aggression, and predator avoid-
ance, which in turn has ecological consequences (Bjo¨rnsson
et al., 2004; Reinecke et al., 2005). GH regulates growth in
all vertebrates, including ﬁsh (Chen et al., 1994).
Thyroid hormone (TH) plays an indispensable role during
embryonic and larval periods of ﬁsh development (Mousa,
2004; Yamano, 2005; Khalil et al., 2011). The injection of fe-
male Oreochromis niloticus with thyroxin greatly enhanced
the production of activin bA in the developing tissues of larvae
(Mousa, 2004). Furthermore, it was demonstrated that the thy-
roid hormone (T3) has increased the steady state levels of
growth hormone messenger RNA in pituitary cells of teleosts
(Moav and McKeown, 1992; Farchi-Pisanty et al., 1995).
For the successful propagation of any species, larval rearing is
considered a major bottleneck (Calzada et al., 1998; Cataldi et al.,
2002). Attempts to rear the Nile tilapia,O. niloticus in the hatcher-
ies in Egypt have yielded inconsistent and unreliable production of
fry. Larval rearing has proven extremely difﬁcult with heavy larval
mortalities usually occurring during the second and third weeks of
hatching. The cause of these mortalities may be physiological in
nature given that starvation, due to the physical inability to feed
after exhaustionof endogenous reserves.Thepossibility to enhance
the growth of ﬁsh by the induction of growth hormone synthesis
may allow for the production of marketable products in shorter
periods of time, and with lower production costs. Therefore, the
present work was designed to describe the effect of exogenous
treatment ofO. niloticus femaleswith L-thyroxin (T4) on the immu-
noreactivity of growth hormone-secreting cells, and its subse-
quent effect on larval growth and survival.
Material and methods
Study site
The present study was carried out at both El-Serw Fish Re-
search Farm and El-Matareyya Research Station between 1
January and 30 August 2012.
Spawning and production of larvae
Before spawning, brood ﬁsh were kept in two ponds, males
and females were separated since January in two different
ponds, they were fed daily with 40% protein diet to ensure a
good quality and quantity of eggs. Medium-size tilapia brood
ﬁsh (150–250 g) were used. Semi-natural spawning was carried
in spawning hapas at the ﬁrst of May (temperature: 23–25 C).
Brood O. niloticus were stocked into 30 ﬁne-mesh 1-m2 spawn-
ing hapas at a rate of 2 males and 4 females per hapa.
The experimental design and treatments
Females were randomly divided into three groups representing
three treatments with ten replicates each. Fish in treatments 1
and 2 were injected once with thyroxin (T4) (Sigma Chemicals
co., St. Louis, MO), dissolved in dimethylsulfoxide (DMSO),
at 1 and 10 lg T4/g BW of ﬁsh, respectively. Fish in treatment
3 were injected only with DMSO and served as controls. Afterinjection, females were stocked with hormonally-untreated
running males and allowed to spawn. Breeding activity was
monitored daily. Once breeding occurred, the other ﬁsh were
removed and the brooding female left to incubate the progeny.
Immediately after hatching the larvae, obtained from each of
the previous groups; control and thyroxin treated groups, were
classiﬁed into three groups (three aquaria for each group). The
density of larvae for each aquarium is about 500 larvae/aquar-
ium i.e. 10 larvae/l. Since the sensitivity of ﬁsh to temperature
is dependent on developmental stage (age), fry from a single
broodwere used in order to control for the time elapsed after fer-
tilization (and therefore, developmental stage). The aquaria
were maintained at 25 C and ambient photoperiod. Water
quality in the aquaria was maintained by partial water exchange
(70%) daily. Gentle aeration was conducted with pressurized
air. The larvae received natural feed of fresh plankton obtained
from the fertilized pond with plankton net.
Larvae sampling and processing
Both standard length (SL) and weight (W) of larvae at hatch-
ing, 1, 4, 7, 14, 21, 28 and 35 days old, were measured for each
group. Twenty larvae were randomly sampled, anaesthetized,
placed on paper towels for about 10 s to remove most of the
adhering water, and individually both, measured and weighed.
At the end of the experiment the surviving number of larvae
for each treatment was determined.
For histological and histochemical study, the larvae were
anaesthetized in a solution (40 mg/l) of clove oil (Sigma) and
ﬁxed in toto in Bouin’s ﬂuid at room temperature for 48 h.
Then, the samples were transferred to 70% alcohol after ﬁxa-
tion and dehydrated through a series of graded ethanol,
cleared in xylene, embedded in paraplast (M.P. 56–58 C)
and serial transverse and longitudinal sections, 5 lm thick,
were cut and mounted on glass slides.
Immunocytochemical procedures
Antibodies
Chum salmon somatotropin (chum GH) (Lot No.8208) was
obtained from Dr. H. Kawauchi (School of Fisheries Science,
Kitasato University, Iwate, Japan).
Immunocytochemical reactions
Immunocytochemical staining was generally performed with a
vectastain ABC (Avidin–biotin peroxidase complex) Kit (Vec-
tor Laboratories) as described previously (Mousa, 1999, 2002;
Mousa and Mousa, 1999a,b). In brief, sections were deparaff-
inized in xylene, rehydrated through graded ethanol, washed in
phosphate-buffered saline (PBS; pH 7.4) for two times 10 min
each. All incubations were done at 4 C and PBS was used for
washing after each step. Sections were incubated with the pri-
mary antibody against chum salmon somatotropin diluted at
1:5000 overnight at 4 C. Thereafter, the sections were incu-
bated with the biotinylated secondary antibody (Vector Labo-
ratories) for 1hr and with avidin–biotin-conjugated peroxidase
for 45 min. Finally, the sections were washed and stained with
3,3-diaminobenzidine tetrahydrochloride (DAB) (Sigma)
including 0.01% H2O2 in 0.05 M Tris-buffered saline (pH
7.6) for 3–5 min. After the enzyme reaction, the sections were
washed in tap water, dehydrated in alcohol, cleared in xylene
and mounted in DPX.
Table 1 Total length (mm), total weight (mg) and GH-immunoreactive cells; cell number, cell size (lm2), integrated optical density
(IOD) and IOD% (% from control) at different ages, of O niloticus larvae from T4-treated and control spawners.
Treatment Larval growth GH-immunoreactive cells
TL (mean ± SD mm) TW (mean ± SD mg) Survival rate (%) Cell number Cell size IOD IOD%
1 day
Control 08.51 ± 0.03 010.75 ± 0.10a – 025 ± 2.5 40 ± 3.55 65.76 ± 5.30 100.00
T1 08.61 ± 0.03 011.22 ± 0.20 – 030 ± 3.0 35 ± 2.30 58.83 ± 3.45 089.46
T2 08.73 ± 0.04 011.45 ± 0.48 – 030 ± 3.2 40 ± 3.20 55.02 ± 4.50 083.67
7 day
Control 09.52 ± 0.03a 014.43 ± 0.63a 92.70 ± 1.50 025 ± 2.5 45 ± 2.95 56.75 ± 3.75 100.00
T1 09.52 ± 0.05
b 015.65 ± 0.38 93.55 ± 1.35b 035 ± 3.5 50 ± 3.15 46.12 ± 2.20 081.27
T2 09.81 ± 0.04 015.90 ± 0.54 96.50 ± 2.10 040 ± 4.0 60 ± 4.00 59.12 ± 6.53 104.18
14 day
Control 12.40 ± 0.63a 028.50 ± 1.52a 71.50 ± 0.72a 035 ± 3.5 33 ± 1.85 56.15 ± 5.35 100.00
T1 13.30 ± 0.41 038.50 ± 3.53
b 86.75 ± 1.52b 040 ± 3.5 41 ± 2.20 62.97 ± 7.35 112.15
T2 13.88 ± 0.33 052.55 ± 2.45 95.05 ± 0.76 055 ± 4.0 40 ± 2.35 74.88 ± 9.35 133.36
21 day
Control 16.40 ± 0.35a 114.65 ± 8.10a 51.85 ± 1.55a 040 ± 2.5 35 ± 2.50 33.15 ± 3.65 100.00
T1 17.90 ± 0.70
b 163.40 ± 7.90b 77.50 ± 1.45b 055 ± 3.0 45 ± 2.75 68.40 ± 5.80 206.33
T2 21.10 ± 0.65 184.30 ± 9.15 93.55 ± 1.55 080 ± 5.0 50 ± 3.20 97.38 ± 9.25 293.76
28 day
Control 25.25 ± 1.62a 267.50 ± 8.90a 45.90 ± 1.80a 055 ± 4.0 45 ± 2.65 58.13 ± 3.55 100.00
T1 28.50 ± 1.62
b 325.30 ± 15.3b 76.65 ± 1.80b 070 ± 3.0 50 ± 3.10 59.55 ± 4.85 102.44
T2 31.10 ± 1.32 384.00 ± 18.70 92.20 ± 1.70 095 ± 5.0 55 ± 3.25 76.70 ± 7.90 131.95
35 day
Control 34.00 ± 1.95a 543.50 ± 26.20a 41.80 ± 1.75a 065 ± 3.0 40 ± 2.55 58.12 ± 4.50 100.00
T1 35.65 ± 1.76
b 745.00 ± 52.55b 75.20 ± 1.72b 075 ± 4.0 45 ± 2.40 61.90 ± 4.95 120.27
T2 44.35 ± 2.55 950.45 ± 45.70 90.95 ± 1.65 100 ± 5.0 45 ± 3.00 76.53 ± 8.65 131.68
a Signiﬁcant differences when compared to T1 and T2 (P< 0.005).
b Signiﬁcant differences when compared to T2 (P< 0.005).
Experimental study on the activation of growth hormone-secreting cells 69In order to conﬁrm the speciﬁcity of the immunoreactive
procedures, adjacent sections were stained according to the
above-described protocol but incubation in the primary antise-
rum was omitted. In addition, normal bovine serum was used
instead of primary antiserum. No positive structures or cells
were found in these sections.Semi-quantiﬁcation of immunostaining
Semi-quantiﬁcation of GH-expressing cells in the pituitary was
calculated from ﬁve sections of each individual larva (10 larvae
for each treatment). Brieﬂy, we stained every fourth section of
the pituitary gland that was serially cut at 4 lm from each ﬁsh
(n= 10). Therefore, we obtained 5 sections starting from the
middle of the pituitary gland of each larva for GH-ir cells
counting using the microscope (40· objective) by an observer
blinded to the experimental protocol. The number of GH-ir
cells for each animal was expressed as the mean ± SD. The
sections were analysed using a Zeiss microscope. The sizes of
GH-ir cells were measured using computerized analysis (the
Image-Pro Analysis package, Media Cybernetics) of digital
images viewed via microscope (Axioskop; Zeiss, Oberkochen,
Germany). The cross-sectional area was measured for a mini-
mum of 25 GH-expressing cells with the nucleus in the plane of
section for each larva.
The GH immunoreactivity was semi-quantiﬁed by Java Im-
age processing and analysis software (ImageJ; open-source im-
age software downloaded from http://rsb.info.nih.gov/ij/). The
area and density of pixels within the threshold values repre-senting immunoreactivity were measured, and the integrated
intensity (the product of the area and mean of grey value)
was calculated. Integrated intensity of controls and treated
groups were compared and statistically analysed.
Statistical analysis
Differences between treatments were tested by one-way ANO-
VA using the treatment as factor of variance. Student–New-
man–Keuls test or Dunn’s test was used to identify
signiﬁcant differences between all groups or compared to the
control, respectively. Statistical signiﬁcance was accepted at
P< 0.05.
Results
The ontogeny of immunoreactive GH-secreting cells
Immediately after hatching, one day post hatching (dph), the
mean total weight of the larvae obtained from control females
was 010.75 ± 0.10 mg. The pituitary of one day post-hatching
larvae is a small mass of cells adhered to the brain ﬂoor
(Fig. 1a). At this time, a weak GH-immunoreactivity was de-
tected, using vectastain ABC kit, in the posterior part of ade-
nohypophysis. The larvae obtained from control females had a
mean total weight of about 014.43 ± 0.63 mg after 7 dph. At
this stage, the pituitary was an oval mass of cells where rostral
and caudal adenohypophyseal regions can be distinguished
(Fig. 1d).
Figure 1 Sagittal sections of O. niloticus larvae immunostained with anti-chum salmon somatotropin. Immunostaining is observed
mainly in the growth hormone-secreting cells in the pituitary gland. (a) One day post hatching (dph) larvae from control female. (b) One
dph larvae from treated female (with the low dose of thyroxin; 1 lg T4/g BW). (c) One dph larvae from treated female (with the high dose
of thyroxin; 10 lg T4/g BW). (d) 7 dph larvae from control female. (e) 7 dph larvae from treated female (with the low dose of thyroxin;
1 lg T4/g BW). (f) 7 dph larvae from treated female (with the high dose of thyroxin; 10 lg T4/g BW). Scale bar = 50 lm.
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from control females was 028.50 ± 1.52 mg. During this stage,
the pituitary gland became more elongated in shape and neu-
rohypophysis was recognized although, no nerve processes
were found to penetrate the adenohypophyseal tissue. Also,
at 14 dph, the characteristic divisions of the pituitary can be
distinguished (Fig. 2a) and GH cells were patent. The larvae
obtained from control females had a mean total weight of
about 114.65 ± 8.10 mg after 21 dph. At this stage, the GH
cells increased in number and became more patent (Fig. 2d).
The adenohypophysis and neural lobe increased in size with
development and, in 28 day old larvae, theywere similar to those
of adults. The number and immunoreactivity of GH-secreting
cells increased with development. At 28 dph, the mean total
weight of the larvae obtained from control females was
267.50 ± 8.90 mg. During this stage, GH cells were increased
in number, size as well as immunoreactivity, and located more
dorsally contact branches of neurohypophyseal tissue that pen-
etrated the PPD (Fig. 3a). The larvae obtained from control fe-males had amean total weight of about 543.50 ± 26.20 mg after
35 dph. By this day, the adenohypophysis and neural lobe in-
creased in size, and GH cells showed further increase in number
and moderate immunoreactivity (Fig. 3d).
The effect of thyroxin treatment on the activity of
immunoreactive GH-secreting cells
The immunoreactivity of GH-secreting cells of O. niloticus was
followed up during the development of larvae, obtained from
control and thyroxin injected females, by the Semi-quantiﬁca-
tion technique. The GH immunoreactivity was semi-quantiﬁed
by Java Image processing and analysis software. The injection
of females with thyroxin enhanced the production of GH in
the developing pituitaries of larvae as indicated by the in-
creased number, size and strong immunoreactivities of GH-
secreting cells (Figs. 1–3).
At 14 dph, the number and size ofGH-expressing cells of lar-
vae, obtained from thyroxin injected females, were signiﬁcantly
Figure 2 Sagittal sections of O. niloticus larvae immunostained with anti-chum salmon somatotropin. Immunostaining is observed
mainly in the growth hormone-secreting cells in the pituitary gland. (a) 14 dph larvae from control female. (b) 14 dph larvae from treated
female (with the low dose of thyroxin; 1 lg T4/g BW). (c) 14 dph larvae from treated female (with the high dose of thyroxin; 10 lg T4/g
BW). (d) 21 dph larvae from control female. (e) 21 dph larvae from treated female (with the low dose of thyroxin; 1 lg T4/g BW). (f)
21 dph larvae from treated female (with the high dose of thyroxin; 10 lg T4/g BW). Scale bar = 50 lm.
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males (P< 0.05, one way ANOVA, Student–Newman–Keuls
test) (Fig. 2 and Table 1). The integrated intensity of GH immu-
noreactivity was higher by 33.36 for larvae of T4-treated females
with high dose of thyroxin (10 lg T4/g BW) and 12.15% for lar-
vae of T4-treated females low dose of thyroxin (1 lg T4/g BW)
compared to that of the control (P< 0.05, one way ANOVA,
Dunn’s test) (Fig. 2 and Table 1).
After, 21 dph, the effect of thyroxin was obvious, since the
integrated intensity of GH immunoreactivity was higher by
193.76% for the larvae of T4-treated females with a high dose
of thyroxin (10 lg T4/g BW) and 106.33% for the larvae of T4-
treated females with a low dose of thyroxin (1 lg T4/g BW)
compared to that of the control (P< 0.05, one way ANOVA,
Dunn’s test) (Fig. 2 and Table 1).
The effect of thyroxin on the activation of GH-expressing
cells was continued also in the old larvae; 28 and 35 dph. At
these stages, the number and size of GH-expressing cells of lar-vae, obtained from thyroxin injected females, were signiﬁcantly
higher compared to that of larvae, obtained from control fe-
males (P< 0.05, one way ANOVA, Student–Newman–Keuls
test) (Fig. 3 and Table 1). In addition, the integrated intensity
of GH immunoreactivity for the larvae of T4-treated females
was higher than that of control (P< 0.05, one way ANOVA,
Dunn’s test) (Fig. 3 and Table 1).
Larval growth and survival
The injection of O. niloticus females with thyroxin (1 or 10 lg
T4/g BW) enhanced larval growth. The larvae of T4-treated fe-
males exhibited signiﬁcantly greater average body length and
weight than those of the control as represented in table (1).
Moreover, treatment with the high dose of thyroxin
(10 lg T4/g BW) gave signiﬁcantly higher increase in both
length and weight of larvae than low dose (1 lg T4/g BW)
(Table 1).
Figure 3 Sagittal sections of O. niloticus larvae immunostained with anti-chum salmon somatotropin. Immunostaining is observed
mainly in the growth hormone-secreting cells in the pituitary gland. (a) 28 dph larvae from control female. (b) 28 dph larvae from treated
female (with the low dose of thyroxin; 1 lg T4/g BW). (c) 28 dph larvae from treated female (with the high dose of thyroxin; 10 lg T4/g
BW). (d) 35 dph larvae from control female. (e) 35 dph larvae from treated female (with the low dose of thyroxin; 1 lg T4/g BW). (f)
35 dph larvae from treated female (with the high dose of thyroxin; 10 lg T4/g BW). Scale bar = 50 lm.
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T4/g BW)) improved larval rearing, since low mortalities occurred
over the rearing period of 35 days. The larvae ofT4-treated females
exhibited signiﬁcantly higher survival rate than control.Moreover,
the injection of females with high dose of thyroxin resulted in
a signiﬁcantly higher survival rate than low dose. The average val-
ues of survival rate were 90.95 ± 1.65%, 75.20 ± 1.72% and
41.80 ± 1.75% for the larvae of T4-treated females with high dose
of thyroxin (10 lgT4/g BW), low dose of thyroxin (1 lgT4/g BW),
and control larvae, respectively.
Discussion
It has been shown that pituitary hormones play important roles
in ﬁsh embryonic development and larval growth (Majumdar
and Elsholtz, 1994; Tanaka et al., 1995). Ontogenetic studies
of pituitary cells in freshwater and seawater teleost species re-
vealed that the onset of their activity varied among species
and cell types. In larvae of O. niloticus, as in other teleost ﬁsh,GH cells were restricted to the dorsal and ventral parts of
PPD (Farbridge and Leatherland, 1986; Folle´nius et al., 1978;
Segura-Noguera et al., 2000; Laiz-Carrı´on et al., 2003). Labelled
GH cells ﬁrst appeared clearly at 1 day post-hatching. Regard-
ing freshwater ﬁshes, GH cells were evident before hatching
(Mal et al., 1989; Naito et al., 1993; Saga et al., 1993). In C. gar-
iepinus, GH cells were visible from hatching time and GH is ac-
tive at the very early stages of development (Volckaert et al.,
1999). However, in the cichlid ﬁsh C. dimerus, GH cells were de-
tected 2 days after hatching (Pandolﬁ et al., 2001).
The physiological role of GH as a growth-promoting hor-
mone has been well established (Pe´rez-Sa´nchez and Le Bail,
1999; Cao et al., 2011). It seems likely that in freshwater tele-
osts GH appears early than in seawater teleost, thus indicating
a putative role of this hormone in embryonic and larval devel-
opment (Pandolﬁ et al., 2001; Einarsdo´ttir et al., 2007). In the
present study, the number and immunoreactivity of GH-
secreting cells increased with larval development. Similarly,
the pituitary GH content was increased proportionally to
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max in Atlantic halibut (Einarsdo´ttir et al., 2007).
The present study examined the effects of exogenous treat-
ment of O. niloticus females with L-thyroxin (T4) on the ontog-
eny and activation of GH-secreting cells during larval
development, and its subsequent effect on larval growth and
survival. The injection of females O. niloticus with thyroxin
(1 or 10 lg T4/g BW) greatly enhanced the immunoreactivity
of GH-secreting cells in the pituitary gland of larvae as indi-
cated by the quantitative and qualitative changes during the
rearing period for the larvae produced from T4-treated fe-
males. Similar observation indicated that thyroid hormone
(T3) has increased the steady state levels of growth hormone
messenger RNA in pituitary cells of carp (Farchi-Pisanty
et al., 1995). Also, treatment of young rainbow trout
(Oncorhynchus mykiss) ﬁsh for one week with thyroid hormone
(T3) (3,3’,5-triiodo-L-thyronine) increased the steady state lev-
els of mRNA for growth hormone in the pituitary 3-4 times as
compared to the control groups (Moav and McKeown, 1992).
Thus, the treatment with L-thyroxin (T4; 1 or 10 lg T4/g BW)
accelerated larval growth, since a higher increase in both, length
and weight of larvae occurred during the experimental period.
This may be due to the direct effect of exogenous thyroxin,
which transferred from maternal circulation into oocytes and
larvae, on the synthesis of growth hormone (the present study)
and activin bA (Mousa, 2004). Treated larvae gave also a signif-
icantly higher survival rate than that of the control. In similar
manner, growth enhancement of juvenile striped mullet was ob-
served by feeding recombinant yeasts containing ﬁsh growth
hormone (Tsaia et al., 1994). In addition, similar reports showed
that thyroid hormones improve survival rates and accelerate
growth and development in teleost larvae (Ansal and Kaur,
1998; Power et al., 2001; Gavlik et al., 2002; Mousa et al.,
2002; Kang and Chang, 2004; Mousa, 2004; Yamano, 2005).
Improvement of larval development obtained by thyroid hor-
mone treated female is dose-dependent. Larvae obtained from
treated female with high dose of thyroxin (10 lg T4/g BW)
showed signiﬁcantly higher increase in length, weight and sur-
vival rate than those of low dose of thyroxin (1 lg T4/g BW).
Similar dose-dependent manner to thyroid hormone treatment
was observed in milkﬁsh Chanos chanos (Lam et al., 1985), In-
dian major carp Cirrhina mrigala (Ansal and Kaur, 1998),
grouperEpinephelus coioides (de Jesus et al., 1998) and common
carp Cyprinus carpio (Mousa et al., 2002).
In conclusion, this study showed that the chronological
appearance of GH cells in the pituitary of O. niloticus at hatch-
ing time suggesting that the GH may play important physio-
logical functions in embryonic and larval development of O.
niloticus. The transferred thyroid hormone, from maternal cir-
culation to oocytes and larvae, appears to play a main role in
the synthesis and secretion of GH during the early develop-
ment of larvae and may confer a distinct advantage for the
growth of the offspring of Nile tilapia, O. niloticus.
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